期刊文献+

孕妇妊娠中期血清学筛查结果与妊娠结局相关性分析 被引量:1

Analysis of Serological Screening Results of Pregnant Women in the Second Trimester and Pregnancy Outcomes
下载PDF
导出
摘要 目的:分析妊娠中期孕妇血清学筛查结果,探讨不同筛查风险与母胎不良结局的关联。方法:选取2019—2021年在合肥市新站区接受孕中期血清学筛查的孕妇,评估胎儿患21-三体综合征、18-三体综合征和开放性神经管缺陷的风险,分别计算3种疾病高风险和低风险的发生率,并随访获得妊娠结局,分析不同风险组胎儿不良妊娠结局的发生率。结果:在接受妊娠中期血清学筛查的11 821名孕妇中,检出21-三体综合征高风险孕妇560人,检出率为4.74%;检出18-三体综合征高风险孕妇28人,检出率为0.24%;检出开放性神经管缺陷高风险孕妇53人,检出率为0.45%。实际随访获得妊娠结局的孕妇共11 606人,其中,高风险组孕妇自然流产、死胎、出生缺陷和低出生体重的发生率分别为1.12%、1.60%、4.17%和3.37%,显著高于低风险组(0.32%、0.30%、1.16%和2.12%)。高风险组孕妇靶向疾病、其他染色体疾病、其他出生缺陷的发生率分别为1.12%、1.12%和1.44%,均高于低风险组(0.05%、0.02%和0.65%)。结论:妊娠中期血清学筛查高风险与自然流产、死胎、出生缺陷、出生低体重等母胎不良妊娠结局具有一定的相关性,对出生缺陷的预测具有指导意义。 OBJECTIVE To analyze the results of serological screening in the second trimester,and to explore the association be-tween different screening risks for adverse maternal and fetal outcomes.METHODS Pregnant women who underwent second-trimes-ter serological screening in Xinzhan district of Hefei from 2019 to 2021 were selected.The incidences of high--risk and low--risk of 21-trisomy sy ndrome,18-trisomy syndrome and open neural tube defects were counted,and the pregnancy outcomes were followed up to analyze the incidence of adverse matermal--fetal outcomes in different risk groups.RESULTS Among the 11821 pregnant wom-en undergoing serological screening in the second trimester,560 pregnant women with high risk of 21-3 syndrome,with a detection rate of 4.74%;28 pregnant women with high risk of 18-3 syndrome with a detection rate of 0.24%;53 pregnant women with high risk of open neural tube defects,with a detection rate of 0.45%.A total of 11606 pregnant women with pregnancy outcomes,sponta-neous abortion,sillbirth,birth defects and low birth weight were 1.12%,1.60%,4.17%and 3.37%,respectively,signifcantly higher than the low--risk group(0.32%,0.30%,1.16%,2.12%).The incidence of targeted disease,other chromosomal disease,and other birth defects were 1.12%,1.12%,and 1.44%,respectively,all higher than the low risk group(0.05%,0.02%,0.65).CONCLUSION The high risk of serological screening in the second trimester is correlated with adverse matermnal-fetal pregnancy outcomes,such as spontaneous abortion,sillbirth,birth defects and low birth weight,and is instructive for the prediction of birth defects.
作者 黄晓曼 谢钱茹 邵子瑜 HUANG Xiao-man;XIE Qian-ru;SHAO Zi-yu(Hefei Women and Children Health Care Center,Hefei,Anhui,230031,China)
出处 《中国初级卫生保健》 2023年第6期39-41,45,共4页 Chinese Primary Health Care
关键词 孕妇 血清学筛查 唐氏筛查 妊娠结局 优生优育 pregnant women serological screening down screening pregnancy outcomes prenatal and postnatal care
  • 相关文献

参考文献13

二级参考文献78

  • 1任爱国.美国一基金会发布全球出生缺陷报告[J].中国生育健康杂志,2006,17(2):121-122. 被引量:52
  • 2Xie Z, Lu S, Li H. Contingent triple-screening for down syndromein the second trimester: a feasibility study in mainland Chinesepopulation[j]. Prenat Diagn, 2010, 30(1): 74-76. 被引量:1
  • 3Smith-Bindman R, Chu P, Bacchetti P, et al. Prenatal screening forDown syndrome in England and Wales and population-based birthoutcomes[J]. Am J Obstet Gynecol, 2003,189(4): 980-5. 被引量:1
  • 4Demirhan O, Pazarba§i A, Guzel Al, et al. The reliability ofmaternal serum triple test in prenatal diagnosis of fetalchromosomal abnormalities of pregnant Turkish women [J]. GenetTest Mol Biomarkers, 2011, 15(10): 701-7. 被引量:1
  • 5Springett AL, Morris JK. Antenatal detection of Edwards (Trisomy18) and Patau (Trisomy 13) syndrome: England and Wales 2005-2012[J]. J Med Screen, 2014,21(3): 113-9. 被引量:1
  • 6Lim JH, Yang SH, Xu Y, et al. Selection of patients for natural cyclein vitro fertilization combined with in vitro maturation of immatureoocytes[j]. Fertil Steril, 2009, 91(4): 1050-5. 被引量:1
  • 7Baer RJ, Currier RJ, Norton ME, et al. Obstetric, perinatal, and fetaloutcomes in pregnancies with false-positive integrated screeningresults[j]. Obstet Gynecol, 2014,123(3): 603-9. 被引量:1
  • 8Lau TK,Jiang F,Chan MK, et al. Non-invasive prenatal screeningof fetal Down syndrome by maternal plasma DNA sequencing intwin pregnancies [J]. J Matem Fetal Neonatal Med, 2013, 26(4):434-7. 被引量:1
  • 9Angelova L, Gadancheva V, Konstantinova D, et al. Maternalbiochemical screening-an approach for genetic prevention, part 2.sequential approach with integrated risk assessment [j]. AkushGinekol (Sofiia), 2013, 52(5): 14-8. 被引量:1
  • 10Goodbum SF, Yates JR, Raggatt PR, et al. Second-trimestermaternal serum screening using alpha-fetoprotein,human chorionicgonadotrophin, and unconjugated oestriol: experience of a regionalprogramme[j]. Prenat Diagn, 1994, 14(5): 391-402. 被引量:1

共引文献146

同被引文献13

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部